Skip to main content
SpringerLink
Log in

Diagnosis, staging, and treatment of cholangiocarcinoma

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

Attention has to be focused on earlier detection of cholangiocarcinoma, especially in high-risk patients such as those with primary sclerosing cholangitis (PSC). Enhanced techniques for diagnosing this disease include imaging studies such as positron emission tomography (PET) scanning, and cytologic analysis including digital image analysis (DIA) and fluorescent in situ hybridization (FISH). Magnetic resonance imaging and endoscopic ultrasonography have also improved and simplified preoperative staging. Despite recent advances in the endoscopic management of cholangiocarcinoma, this neoplastic disease is still fatal in the majority of patients. Surgical resection or liver transplantation offers the only possibility for curing this disease in its early stages. However, most patients present with advanced disease that is not amenable to such therapy. For those patients presenting with unresectable carcinoma above the cystic duct without intrahepatic or extrahepatic metastases, orthotopic liver transplantation combined with preoperative irradiation and chemotherapy is available and demonstrates improved survival on the basis of a recent study conducted at the Mayo Clinic. In the future, chemopreventive strategies aimed at blocking the links between inflammation (eg, nitric oxide synthase [iNOS] and cylcooxygenase 2 [COX-2] inhibitors) and carcinogenesis may help prevent this often fatal disease in high-risk patients (eg, patients with PSC).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001, 33:1353–1357.

    Article  PubMed  CAS  Google Scholar 

  2. Taylor-Robinson SD, Toledano MB, Arora S, et al.: Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut 2001, 48:816–820.

    Article  PubMed  CAS  Google Scholar 

  3. Henson DE, Albores-Saavedra J, Corle D: Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates. Cancer 1992, 70:1498–1501.

    Article  PubMed  CAS  Google Scholar 

  4. de Groen PC, Gores GJ, LaRusso NF, et al.: Biliary tract cancers. N Engl J Med 1999, 341:1368–1378.

    Article  PubMed  Google Scholar 

  5. Tocchi A, Mazzoni G, Liotta G, et al.: Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients. Ann Surg 2001, 234:210–214. A recent clinical study showing the link between chronic inflammation and the development of cholangiocarcinoma.

    Article  PubMed  CAS  Google Scholar 

  6. Rumalla A, Baron TH, Leontovich O, et al.: Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc 2001, 76:29–33.

    Article  PubMed  CAS  Google Scholar 

  7. Patel AH, Harnois DM, Klee GG, et al.: The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000, 95:204–207. A report on the usefulness of a serum CA 19-9 determination in the differential diagnosis of de novo cholangiocarcinoma.

    Article  PubMed  CAS  Google Scholar 

  8. Keiding S, Hansen SB, Rasmussen HH, et al.: Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998, 28:700–706.

    Article  PubMed  CAS  Google Scholar 

  9. Rice HM, Chapman WC, Pinson CW, Delbeke D: Role of FDG PET imaging in the evaluation of cholangiocarcinomas: nodular vs. infiltrating subtypes. J Nucl Med 2003, In press.

  10. Braga HJ, Imam K, Bluemke DA: MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension. AJR Am J Roentgenol 2001, 177:111–114.

    PubMed  CAS  Google Scholar 

  11. Fritscher-Ravens A, Broering DC, Sriram PV, et al.: EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest Endosc 2000, 52:534–540.

    Article  PubMed  CAS  Google Scholar 

  12. Ahrendt SA, Nakeeb, A, Pitt HA: Cholangiocarcinoma. Clin Liver Dis 2001, 5:191–218.

    Article  PubMed  CAS  Google Scholar 

  13. Rosen CB, Nagorney DM, Wiesner RH, et al.: Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991, 213:21–25.

    Article  PubMed  CAS  Google Scholar 

  14. Pichlmayr R, Weimann A, Ringe B: Indications for liver transplantation in hepatobiliary malignancy. Hepatology 1994, 20:33S-40S.

    PubMed  CAS  Google Scholar 

  15. Goldstein RM, Stone M, Tillery GW, et al.: Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993, 166:768–771; discussion 771–762.

    Article  PubMed  CAS  Google Scholar 

  16. Flickinger JC, Epstein AH, Iwatsuki S, et al.: Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases. Cancer 1991, 68:289–294.

    Article  PubMed  CAS  Google Scholar 

  17. Gores GJ: Early detection and treatment of cholangiocarcinoma. Liver Transplant 2000, 6:S30–34.

    Article  CAS  Google Scholar 

  18. De Vreede I, Steers JL, Burch PA, et al.: Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transplant 2000, 6:309–316. A promising report of prolonged disease-free and overall survival in highly selected patients with early-stage cholangiocarcinoma, who received OLT in combination with preoperative irradiation and chemotherapy.

    Article  Google Scholar 

  19. Iwatsuki S, Todo S, Marsh JW, et al.: Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998, 187:358–364. An early report on long-term disease-free survival in cholangiocarcinoma patients undergoing OLT with accompanying radiation therapy.

    Article  PubMed  CAS  Google Scholar 

  20. Urego M, Flickinger JC, Carr BI: Radiotherapy and multimodality management of cholangiocarcinoma. Int J Radiat Oncol Biol Phys 1999, 44:121–126.

    Article  PubMed  CAS  Google Scholar 

  21. Banerjee B, Teplick SK: Nonsurgical management of primary cholangiocarcinoma. Retrospective analysis of 40 cases. Dig Dis Sci 1995, 40:701–705.

    Article  PubMed  CAS  Google Scholar 

  22. Davids PH, Groen AK, Rauws EA, et al.: Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992, 340:1488–1492.

    Article  PubMed  CAS  Google Scholar 

  23. Shim CS, Lee YH, Cho YD, et al.: Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Endoscopy 1998, 30:345–350.

    PubMed  CAS  Google Scholar 

  24. Gunderson LL, Haddock MG, Foo ML, et al.: Conformal irradiation for hepatobiliary malignancies. Ann Oncol 1999, 10:221–225.

    Article  PubMed  Google Scholar 

  25. Foo ML, Gunderson LL, Bender CE, Buskirk SJ: External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 1997, 39:929–935.

    Article  PubMed  CAS  Google Scholar 

  26. Eschelman DJ, Shapiro MJ, Bonn J, et al.: Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy. Radiology 1996, 200:717–724.

    PubMed  CAS  Google Scholar 

  27. Leung JT, Kuan R: Intraluminal brachytherapy in the treatment of bile duct carcinomas. Australas Radiol 1997, 41:151–154.

    PubMed  CAS  Google Scholar 

  28. Gomer CJ, Rucker N, Ferrario A, Wong S: Properties and applications of photodynamic therapy. Radiat Res 1989, 120:1–8.

    Article  PubMed  CAS  Google Scholar 

  29. Ortner MA, Liebetruth J, Schreiber S, et al.: Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998, 114:536–542.

    Article  PubMed  CAS  Google Scholar 

  30. Kubicka S, Rudolph KL, Tietze MK, et al.: Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology 2001, 48:783–789.

    PubMed  CAS  Google Scholar 

  31. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ: Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 2000, 60:184–190.

    PubMed  CAS  Google Scholar 

  32. Jaiswal M, LaRusso NF, Nishioka N, et al.: Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res 2001, 61:6388–6393.

    PubMed  CAS  Google Scholar 

  33. Torok NJ, Higuchi H, Bronk S, Gores GJ: Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9. Cancer Res 2002, 62:1648–1653.

    PubMed  CAS  Google Scholar 

  34. Gupta RA, DuBois RN: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001, 1:11–21.

    Article  PubMed  CAS  Google Scholar 

  35. Hayashi N, Yamamoto H, Hiraoka N, et al.: Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology 2001, 34:638–650.

    Article  PubMed  CAS  Google Scholar 

  36. Byrnes V, Afdhal N: Cholangiocarcinoma of the hepatic hilum (Klatskin tumor). Curr Treat Options Gastroenterol 2002, 5:87–94. A recent comprehensive review on cholangiocarcinoma treatment with special emphasis on curative surgical therapies, including local tumor resection/partial hepatectomy, and palliative treatment modalities, including endoscopic therapy.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic, and Foundation, 200 First Street SW, 55905, Rochester, MN, USA

    Jung-Hwan Yoon MD & Gregory J. Gores MD

Authors
  1. Jung-Hwan Yoon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregory J. Gores MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoon, JH., Gores, G.J. Diagnosis, staging, and treatment of cholangiocarcinoma. Curr Treat Options Gastro 6, 105–112 (2003). https://doi.org/10.1007/s11938-003-0011-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-003-0011-z

Keywords

Search

Navigation